Skip to content

Propolis Effects in Patients With Chronic Kidney Disease

Propolis Effects on Proteinuria and Kidney Function in Patients With Chronic Kidney Disease

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02766036
Enrollment
32
Registered
2016-05-09
Start date
2016-12-01
Completion date
2018-03-31
Last updated
2018-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases

Keywords

Proteinuria, Propolis, Chronic Kidney Disease

Brief summary

The aim of this study is to determine the impact of Propolis on proteinuria reduction and protection of the glomerular filtration rate in chronic renal failure patients.

Interventions

DRUGPropolis

Patients will receive 500 mg / day of the propolis extract in the form of tablets split in two daily doses

DRUGPlacebo

Patients will receive 500 mg / day of the placebo in the form of tablets split in two daily doses

Sponsors

University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* older than 18 years; * less than 90 years; * glomerular filtration rate between 25 and 70 ml / min; * proteinuria in the urine 24 hours more than 300 mg or protein / creatinina in isolated urine greater than 0.3g / g or microalbuminuria (albumin / creatinine ratio) between 30-300 mg / g.

Exclusion criteria

* Pregnants; * Neoplasia carrier; * Renal transplant patients; * Patients who refuse to participate in the study. * Glomerulopathy on Immunosuppression

Design outcomes

Primary

MeasureTime frameDescription
Reducing ProteinuriaOne yearReduction from baseline proteinuria.

Secondary

MeasureTime frameDescription
Protection of the glomerular filtration rateOne yearMaintaining glomerular filtration rate or inferior reduction to 5 ml per minute per 1.73 m2 of body-surface area from baseline.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026